Back
Resmed Inc (RMD)
Health CareRMD · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$230.05
+1.46%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$10.43
ROE
25.2%
Gross margin
62.2%
Debt/Equity
0.13x
Revenue growth
10.8%
Resmed Inc — company intelligence
Earnings surprises
Q4 2026$2.95 vs $2.92 est+1.1%
Q3 2026$2.86 vs $2.82 est+1.3%
Q2 2026$2.81 vs $2.75 est+2.1%
Q1 2026$2.55 vs $2.58 est-1.2%
Analyst consensus · 27 analysts
13 Buy12 Hold2 Sell
Updated Oct 10, 2026
Insider activity · 90 days
4 buys2 sellsnet +23,340 shares
Farrell Michael J.other 4,991 · Sep 8, 2026
FARRELL PETER CSell 970 · Sep 2, 2026
Bloomer AaronBuy 9,072 · Aug 14, 2026
Recent SEC filings
4 — Insider transaction reportOct 8, 2026
DEF 14A — Proxy statementOct 1, 2026
4 — Insider transaction reportOct 1, 2026
Latest news
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures — Yahoo · 3w ago
This Analyst Just Upgraded ResMed Stock. Here's Why. — Yahoo · 3w ago
RBC Capital Upgrades ResMed to Outperform from Sector Perform — Fintel · 3w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.